Sign Up to like & get
recommendations!
0
Published in 2022 at "Birth Defects Research"
DOI: 10.1002/bdr2.2002
Abstract: The novel potassium competitive acid blocker, KFP‐H008, developed to overcome the shortcomings of proton pump inhibitors. In this study, KFP‐H008 was administered by oral gavage at doses of 0 (control), 15, 45, and 150 mg/kg to…
read more here.
Keywords:
sprague dawley;
dawley rats;
toxicokinetic study;
study kfp ... See more keywords